Flumazenil (Claris Lifesciences Inc.)
Welcome to the PulseAid listing for the Flumazenil drug offered from Claris Lifesciences Inc.. This Benzodiazepine Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Claris Lifesciences Inc. |
| NON-PROPRIETARY NAME: | Flumazenil |
| SUBSTANCE NAME: | FLUMAZENIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Benzodiazepine Antagonist [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-10-01 |
| END MARKETING DATE: | 0000-00-00 |
Flumazenil HUMAN PRESCRIPTION DRUG Details:
| Item Description | Flumazenil from Claris Lifesciences Inc. |
| LABELER NAME: | Claris Lifesciences Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.1(mg/mL) |
| START MARKETING DATE: | 2017-10-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 36000-148_f90dbd33-58d8-4c88-a961-8a9b02ee229b |
| PRODUCT NDC: | 36000-148 |
| APPLICATION NUMBER: | ANDA076755 |
Other FLUMAZENIL Pharmaceutical Manufacturers / Labelers:
